JJP Biologics
Tomasz Sitar is an accomplished professional in the field of biochemistry and molecular biology, currently serving as the Chief Executive Officer and Co-Founder of Recepton Sp. z o.o. since February 2016, while also leading the CMC division at JJP Biologics since April 2022. Prior to these roles, Tomasz held various key positions at Polpharma Biologics, including Bioprocess Development Key Expert and R&D Senior Scientist, from December 2011 to March 2022. Academic credentials include a Ph.D. in Biochemistry and Molecular Biology from the Technical University of Munich and a Master's degree in Biotechnology from Jagiellonian University. Additionally, a postdoctoral fellowship at the Max Planck Institute for Biochemistry was completed from July 2007 to December 2011.
This person is not in the org chart
This person is not in any teams
JJP Biologics
JJP Biologics is an innovative Polish biotechnology company developing novel biological therapies around established companion diagnostics. Our range of programs are in early stage development and we are actively seeking to cooperate with investors and academics on new or existing projects.